As of April 2026, the S&P 500 and Nasdaq have recently hit record highs, but several sectors still offer "buy low" opportunities due to industry-specific pullbacks or valuation gaps. Undervalued Tech & Growth

: Regarded by some analysts as one of the most undervalued hyper-growth companies, currently trading at a deep discount to U.S. tech counterparts. High-Yield "Value" Plays

: Despite strong performance, some analysts still view it as undervalued relative to its long-term cash flow potential and "Dividend King" status.

While tech as a whole has rallied, some major players are trading at discounted multiples compared to historical averages or peers.

: Currently undervalued as it spins off its lower-margin diabetes unit to focus on high-growth surgical tech.

: Trading at a forward P/E of roughly 12.1x, which is lower than the integrated systems industry average of 17.2x.